Kobe, Japan

Yukuo Yoshida



Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 57(Granted Patents)


Company Filing History:


Years Active: 2002-2010

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Yukuo Yoshida: Innovator in Visual Function Disorders

Introduction

Yukuo Yoshida is a prominent inventor based in Kobe, Japan. He has made significant contributions to the field of visual function disorders, holding a total of 7 patents. His work focuses on developing innovative treatments for various eye diseases.

Latest Patents

Yoshida's latest patents include a visual function disorder improving agent. This agent contains a compound with Rho kinase inhibitory activity, specifically (R)-(+)-N-(1H-pyrrolo[2,3-b]pyridin-4-yl)-4-(1-aminoethyl)benzamide. It promotes the extension of retinal ganglion cell axons and optic nerve cell regeneration, making it useful for treating visual function disorders associated with eye diseases caused by damage or degeneration. Another notable patent addresses remedies for dry eye and related diseases. These remedies contain peptides represented by a specific general formula, which are designed to alleviate symptoms associated with dry eye conditions.

Career Highlights

Throughout his career, Yukuo Yoshida has worked with notable companies, including Senju Pharmaceutical Co., Ltd. His innovative research and development efforts have led to advancements in treatments for eye-related disorders.

Collaborations

Yoshida has collaborated with esteemed colleagues such as Mitsuyoshi Azuma and Masayoshi Uehata. Their combined expertise has contributed to the success of various projects in the field of ophthalmology.

Conclusion

Yukuo Yoshida's contributions to the field of visual function disorders highlight his dedication to improving eye health through innovative treatments. His patents and collaborations reflect a commitment to advancing medical science for the benefit of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…